Vascular Medicine News

PHILADELPHIA — In patients with stable angina and evidence of ischemia, PCI improved angina symptoms at 12 weeks compared with a sham procedure, according to the results from the ORBITA-2 trial.

PHILADELPHIA — In patients with acute MI and anemia, there was no difference between liberal and restrictive transfusion strategies for the composite outcome of death and MI at 30 days, according to results of the MINT trial.

NASHVILLE, Tenn. — Venous tumor thrombus appeared associated with elevated rates of pulmonary metastasis among patients with clear cell renal cell carcinoma, according to study results.

Healio and Cardiology Today have aggregated news you may have missed from TCT 2023 in San Francisco.

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder.

Active cancer during transcatheter aortic valve replacement did not increase in-hospital mortality, but certain cancer types were tied to elevated rehospitalization and major bleeding risk in the following months, researchers reported.

The FDA approved the first renal denervation device to treat adults with hypertension not adequately controlled with lifestyle changes and medications, ReCor Medical announced.

DENVER — Integrating lifestyle coaching in a primary care model was feasible and significantly improved several dietary measures and health outcomes, according to data presented at the Lifestyle Medicine Conference.

SAN FRANCISCO — In a new meta-analysis, researchers reaffirmed safety and efficacy of ticagrelor monotherapy to reduce major bleeding after 3-month dual antiplatelet therapy among patients who underwent PCI for ACS.